autologous ex vivo expanded CD4+-enriched leukocytes treated with the de-methylating agent 5-aza-2â⿬⿢-deoxycytidine

autologous ex vivo expanded CD4+-enriched leukocytes treated with the de-methylating agent 5-aza-2â⿬⿢-deoxycytidine
Trade Name Alecsat
Orphan Indication Glioblastoma multiforme
USA Market Approval USA
USA Designation Date 2013-09-13 00:00:00
Sponsor CytoVac A/S;Science & Technology Park Scion DTU, DK-2970;Horsholm